News
Evidence Generation – on the road to standardisation along the life-cycle of health technology
The EUnetHTA JA 2 activities addressed all relevant phases of the Life Cycle of health technology development including the pre-licensing phase (in early scientific advice
ΕΜΑ and EUnetHTA review outcome of joint 2012-2015 work plan
The European Medicines Agency (EMA) and the European network for Health Technology Assessment (EUnetHTA) published today a report on their implementation of the joint work
[CLOSED] Public consultation on the draft methodological reflection paper “Personalised medicine and co-dependent technologies, with a special focus on study design issues”
We are pleased to announce that as of today, 11March 2016, the draft methodological reflection paper “Personalised medicine and co-dependent technologies, with a special focus
EUnetHTA JA2 joint assessments – both output and process matters for successful national uptake
One of the specific objectives of JA2 was to test the capacity of national HTA bodies to produce structured core HTA information (including rapid Relative
EUnetHTA JA3 kick-off meeting was held in Amsterdam, Netherlands, on March 3, 2016
“Support for a more centralized European approach to evaluating new health technologies is gaining pace among the national and regional officials who perform this work
EUnetHTA Evidence Submission Template – a practical tool for technology developers and assessors
During the past 3 years of EUnetHTA’s operations in the framework of the Joint Action 2, an expanded suite of practical approaches and tools for
EMA-EUnetHTA meeting summary, November 23, 2015, Copenhagen, Denmark
The last meeting of EMA-EUnetHTA in the framework of the EUnetHTA JA2 activities took place on November 23, 2015 and hosted by the Danish Health
HTA Core Model® gets an update – open for use by anyone
EUnetHTA JA2 delivers an upgraded universal HTA Core Model for flexible application across health technologies. The updated HTA Core Model Licence and Guiding Principles on
Call for Expression of Interest Multi HTA Early Dialogues – Pharmaceuticals
A call for Expression of Interest to participate in EUnetHTA JA3 Early Dialogues has now been published. A call for Expression of Interest to participate
Updated EVIDENT database
The Evidence database on new technologies (EVIDENT Database) stores information on assessment, coverage and recommendations/requests for additional studies arising from HTA reports for promising technologies
